Holly Maloney, managing director at General Catalyst, emphasizes the need for digital health stakeholders to focus on improving care access, outcomes, cost, and workforce retention. She discusses the potential for AI to assist with the administrative burden in healthcare and drive truly personalized solutions. Maloney also anticipates continued healthy funding at early stages in 2024, driven by exceptional founders and the mission-driven nature of the industry. She highlights the potential for creative consolidation and the commitment to transformation, such as General Catalyst’s purchase of a healthcare system. Maloney also mentions the mass rise in the adoption of GLP-1s and the need to rethink pricing and funding mechanisms for specialty drugs.
Source link
Q&A: General Catalyst on AI and digital health funding in 2024
